These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26696548)

  • 21. Discovery of novel biaryl sulfonamide based Mcl-1 inhibitors.
    Follows B; Fessler S; Baumeister T; Campbell AM; Zablocki MM; Li H; Gotur D; Wang Z; Zheng X; Molz L; Nguyen C; Herbertz T; Wang L; Bair K
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2375-2382. PubMed ID: 31235261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation and critical assessment of putative MCL-1 inhibitors.
    Varadarajan S; Vogler M; Butterworth M; Dinsdale D; Walensky LD; Cohen GM
    Cell Death Differ; 2013 Nov; 20(11):1475-84. PubMed ID: 23832116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax.
    Kour S; Rana S; Contreras JI; King HM; Robb CM; Sonawane YA; Bendjennat M; Crawford AJ; Barger CJ; Kizhake S; Luo X; Hollingsworth MA; Natarajan A
    Mol Pharmacol; 2019 Oct; 96(4):419-429. PubMed ID: 31467029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small molecule Mcl-1 inhibitors for the treatment of cancer.
    Belmar J; Fesik SW
    Pharmacol Ther; 2015 Jan; 145():76-84. PubMed ID: 25172548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MCL-1 inhibitors - where are we now (2019)?
    Fletcher S
    Expert Opin Ther Pat; 2019 Nov; 29(11):909-919. PubMed ID: 31566022
    [No Abstract]   [Full Text] [Related]  

  • 26. Discovery and development of substituted tyrosine derivatives as Bcl-2/Mcl-1 inhibitors.
    Liu R; Liu L; Liu T; Yang X; Wan Y; Fang H
    Bioorg Med Chem; 2018 Sep; 26(17):4907-4915. PubMed ID: 30170927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer.
    Goodwin CM; Rossanese OW; Olejniczak ET; Fesik SW
    Cell Death Differ; 2015 Dec; 22(12):2098-106. PubMed ID: 26045046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bcl-xL inhibitors.
    Li R; Cheng C; Balasis ME; Liu Y; Garner TP; Daniel KG; Li J; Qin Y; Gavathiotis E; Sebti SM
    Eur J Med Chem; 2015 Jan; 90():315-331. PubMed ID: 25437618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia.
    Pan R; Ruvolo VR; Wei J; Konopleva M; Reed JC; Pellecchia M; Andreeff M; Ruvolo PP
    Blood; 2015 Jul; 126(3):363-72. PubMed ID: 26045609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allosteric inhibition of antiapoptotic MCL-1.
    Lee S; Wales TE; Escudero S; Cohen DT; Luccarelli J; Gallagher CG; Cohen NA; Huhn AJ; Bird GH; Engen JR; Walensky LD
    Nat Struct Mol Biol; 2016 Jun; 23(6):600-7. PubMed ID: 27159560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.
    Nalluri S; Peirce SK; Tanos R; Abdella HA; Karmali D; Hogarty MD; Goldsmith KC
    Cancer Biol Ther; 2015; 16(2):276-86. PubMed ID: 25756510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BH3-only proteins are dispensable for apoptosis induced by pharmacological inhibition of both MCL-1 and BCL-X
    Greaves G; Milani M; Butterworth M; Carter RJ; Byrne DP; Eyers PA; Luo X; Cohen GM; Varadarajan S
    Cell Death Differ; 2019 Jun; 26(6):1037-1047. PubMed ID: 30185825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro-apoptotic carboxamide analogues of natural fislatifolic acid targeting Mcl-1 and Bcl-2.
    Gapil Tiamas S; Daressy F; Abou Samra A; Bignon J; Steinmetz V; Litaudon M; Fourneau C; Hoong Leong K; Ariffin A; Awang K; Desrat S; Roussi F
    Bioorg Med Chem Lett; 2020 Apr; 30(7):127003. PubMed ID: 32035700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloid cell leukemin-1 inhibitors: a growing arsenal for cancer therapy.
    Zhu PJ; Yu ZZ; You QD; Jiang ZY
    Drug Discov Today; 2020 Oct; 25(10):1873-1882. PubMed ID: 32771436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Bcl-2 homology-3 domain-like sequences identified from screening randomized peptide libraries for inhibitors of the pro-survival Bcl-2 proteins.
    Lee EF; Fedorova A; Zobel K; Boyle MJ; Yang H; Perugini MA; Colman PM; Huang DC; Deshayes K; Fairlie WD
    J Biol Chem; 2009 Nov; 284(45):31315-26. PubMed ID: 19748896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of tricyclic indoles that potently inhibit Mcl-1 using fragment-based methods and structure-based design.
    Burke JP; Bian Z; Shaw S; Zhao B; Goodwin CM; Belmar J; Browning CF; Vigil D; Friberg A; Camper DV; Rossanese OW; Lee T; Olejniczak ET; Fesik SW
    J Med Chem; 2015 May; 58(9):3794-805. PubMed ID: 25844895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo design, synthesis and evaluation of benzylpiperazine derivatives as highly selective binders of Mcl-1.
    Ding X; Li Y; Lv L; Zhou M; Han L; Zhang Z; Ba Q; Li J; Wang H; Liu H; Wang R
    ChemMedChem; 2013 Dec; 8(12):1986-2014. PubMed ID: 24124106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fragment-based discovery of potent inhibitors of the anti-apoptotic MCL-1 protein.
    Petros AM; Swann SL; Song D; Swinger K; Park C; Zhang H; Wendt MD; Kunzer AR; Souers AJ; Sun C
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1484-8. PubMed ID: 24582986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide and Small Molecule Inhibitors Targeting Myeloid Cell Leukemia 1 (Mcl-1) as Novel Antitumor Agents.
    Lu X; Liang H; Orvig C; Chen ZF
    Curr Mol Med; 2021; 21(5):426-439. PubMed ID: 32990536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloid cell leukemia 1 (MCL-1): Structural characteristics and application in cancer therapy.
    Mittal P; Singh S; Sinha R; Shrivastava A; Singh A; Singh IK
    Int J Biol Macromol; 2021 Sep; 187():999-1018. PubMed ID: 34339789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.